STOCKSBiotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's RiskBy Adam FeuersteinMar 24, 2017 8:34 AM EDT
STOCKSBiotech stock mailbag: Trump, Aurinia, Immunomedics, CellceutixBy Adam FeuersteinJan 27, 2017 8:13 AM EST
STOCKSBiotech School: when Cellceutix CEO rants about 'criminal' short, smart investors see red flagsBy Adam FeuersteinJan 23, 2017 6:00 AM EST
STOCKSSeeking Alpha Author Used Multiple Aliases to Tout Biotech StocksBy Adam FeuersteinJan 28, 2013 6:34 AM EST
TECHNOLOGYCheap Tickets Up as Cendant Extends Share Offer DeadlineBy TSC StaffSep 24, 2001 8:23 AM EDT
STOCKSTicker-Tape Parade: Applied Micro, Merrill Lead Warnings HeadlinesBy Eric GillinJun 26, 2001 10:01 AM EDT
PERSONAL FINANCEThe Daily Interview: Online Travel Skies Getting Crowded By Yoon ChoJun 13, 2001 10:53 AM EDT
TECHNOLOGYpriceline's Remaining Fans Search for a Shred of HopeBy Katherine HobsonNov 1, 2000 6:19 PM EST
MARKETSMomentum Carries Nasdaq to Yet Another Record Despite BreadthBy Robert MannDec 6, 1999 6:04 PM EST
MARKETS'Pullbacks Are for Wimps!' Cries Nasdaq, Building on GainsBy Justin LahartDec 6, 1999 1:01 PM EST
INVESTINGExpedia More Than Triples in Price in Its Trading DebutBy Carolyn KooNov 10, 1999 6:18 PM EST
MARKETSeBay Plummets After Hours; GTE Sells Oklahoma PropertiesBy Tara MurphyOct 26, 1999 9:39 PM EDT
TECHNOLOGYAfter Beating Street Estimates, eBay Can't Keep Declines at BayBy David ShabelmanJul 27, 1999 10:51 AM EDT
